Kalaris Therapeutics (KLRS) Depreciation & Amortization (CF) (2020 - 2026)
Kalaris Therapeutics' Depreciation & Amortization (CF) came in at $10,000 for Q2 2026, unchanged from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kalaris Therapeutics reported Depreciation & Amortization (CF) of $171,000; for FY2025, it came in at $13,000.
- Depreciation & Amortization (CF) carries a five-year compound annual growth rate of -29.2% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $398,000 in FY2023 (-45.0%), $723,000 in FY2022 (+282.5%) and $189,000 in FY2021 (+158.9%).
- The five-year range for quarterly Depreciation & Amortization (CF) is $10,000 (Q4 2025) to $466,000 (Q1 2022).
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2021 (growth of 422.2%), and the weakest in Q1 2023 (a decline of 81.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | 10,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2023 | 141,000.00 |
| Sep 30, 2023 | 86,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 86,000.00 |
| Dec 31, 2022 | 86,000.00 |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Mar 31, 2022 | 466,000.00 |
| Dec 31, 2021 | 94,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 33,000.00 |
| Mar 31, 2021 | 18,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Sep 30, 2020 | 18,000.00 |
| Jun 30, 2020 | 19,000.00 |
| Mar 31, 2020 | 18,000.00 |
API Access
Kalaris Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();